Novel Technologies Across the Spectrum
We actively develop, acquire, and market wound care products that exhibit innovative technologies, empower caregivers, and focus on the unmet needs of patients. As the science underlying the issues of chronic wounds advances, our goal is to be a leader in the development of active therapies.
Several significant new advanced wound care products offer unique therapeutic opportunities: MEDIHONEY®, TCC-EZ®, XTRASORB®, BIOGUARD® and ALGICELL® Ag.
In the mid 1980’s, exciting new data began to drive the way clinicians managed hard-to-heal chronic and acute wounds. This new data suggested that, contrary to the notion that a wound would heal better if left exposed to air, in fact a moist environment is more conducive to wound healing. Products to provide a moist and occlusive environment began to create the market for what are considered “advanced wound care dressings”.
Derma Sciences developed Dermagran® Ointment and Dermagran®-B Hydrophilic Wound Dressings to take that theory one step further by additionally promoting skin protection with the addition of zinc acetate.
In order to satisfy complete protocols of care for chronic and hard-to-heal wounds, Derma Sciences also offers a full line of the common advanced wound care dressings including: